E-LIB Suche - Ergebnisse für: Vermehren, J.

1

NS5A resistance patterns and treatment outcomes in DAA-naiv..:

Dietz, J. ; Vermehren, J. ; Susser, S....
Journal of Hepatology. 68 (2018) - p. S23 , 2018

Link: https://doi.org/10.1016/..

2

Impact of HBV genotype and mutations on HBV DNA and qHBsAg ..:

Kuhnhenn, L. ; Jiang, B. ; Kubesch, A....
Alimentary Pharmacology & Therapeutics. 47 (2018) 11 - p. 1523-1535 , 2018

Link: https://doi.org/10.1111/..

3

Letter: adoption of uniform nomenclature is crucial for est..:

Mücke, M. M. ; Mücke, V. T. ; Vermehren, J.
Alimentary Pharmacology & Therapeutics. 47 (2018) 11 - p. 1573-1574 , 2018

Link: https://doi.org/10.1111/..

4

Impact of antibiotic prophylaxis of spontaneous bacterial p..:

Mücke, M. ; Mayer, A. ; Kessel, J....
Journal of Hepatology. 68 (2018) - p. S746-S747 , 2018

Link: https://doi.org/10.1016/..

5

Clinical and virological characteristics of DAA-experienced..:

Vermehren, J. ; Dietz, J. ; Peiffer, K.-H....
Journal of Hepatology. 68 (2018) - p. S285 , 2018

Link: https://doi.org/10.1016/..

6

HBsAg transcomplementation of defective HBV genomes in HBeA..:

Peiffer, K.-H. ; Kuhnhenn, L. ; Jiang, B....
Journal of Hepatology. 68 (2018) - p. S775 , 2018

Link: https://doi.org/10.1016/..

7

High efficacy of sofosbuvir/velpatasvir and impact of basel..:

von Felden, J. ; Vermehren, J. ; Ingiliz, P....
Alimentary Pharmacology & Therapeutics. 47 (2018) 9 - p. 1288-1295 , 2018

Link: https://doi.org/10.1111/..

8

Editorial: genotype 3 HCV—who still needs ribavirin in a pa..:

von Felden, J. ; Vermehren, J. ; Schulze zur Wiesch, J...
Alimentary Pharmacology & Therapeutics. 47 (2018) 11 - p. 1550-1551 , 2018

Link: https://doi.org/10.1111/..

9

Disease progression is affected by pattern of serum alanine..:

Knop, V. ; Vermehren, J. ; Petersen, Jörg...
Journal of Hepatology. 68 (2018) - p. S496 , 2018

Link: https://doi.org/10.1016/..

10

A175 CAN HCV CORE ANTIGEN REPLACE HCV RNA TESTING IN THE ER..:

Almarzooqi, S ; van Tilborg, M ; Maan, R...
Journal of the Canadian Association of Gastroenterology. 1 (2018) suppl_1 - p. 305-306 , 2018

Link: https://doi.org/10.1093/..

11

Letter: the potential risk of HBV reactivation in patients ..:

Mücke, M. M. ; Mücke, V. T. ; Vermehren, J.
Alimentary Pharmacology & Therapeutics. 46 (2017) 7 - p. 703-704 , 2017

Link: https://doi.org/10.1111/..

12

Correlation of hepatitis B virus genomic variants with HBsA..:

Peiffer, K.-H. ; Sommer, L. ; Susser, S....
Journal of Hepatology. 66 (2017) 1 - p. S248 , 2017

Link: https://doi.org/10.1016/..

13

Letter: low rates of HBV serology testing in patients with ..:

Mücke, M. M. ; Mücke, V. T. ; Vermehren, J.
Alimentary Pharmacology & Therapeutics. 46 (2017) 9 - p. 909-910 , 2017

Link: https://doi.org/10.1111/..

14

Clinical and virological characteristics of patients with c..:

Vermehren, J. ; Dietz, J. ; Schott, E....
Journal of Hepatology. 66 (2017) 1 - p. S520 , 2017

Link: https://doi.org/10.1016/..

15

P486 Immunization status of children and adolescents with i..:

Cagol, L. ; Frivolt, K. ; Krahl, A....
Journal of Crohn's and Colitis. 11 (2017) suppl_1 - p. S326-S326 , 2017

Link: https://doi.org/10.1093/..